knowledge and experience with
internationally recognised best practices
and ethical standards. We advise and
represent, instead of "selling".
Fertility Ukraine is a full-service assisted reproduction agency. Our main focus is on cross-border reproductive care. We assist people worldwide by facilitating the entire process and all stages of their journey in achieving parenthood through the donation of gametes and Ukrainian surrogacy programs here.
Our agency was founded in 2019 by Roman Kolos (attorney-at-law and partner with the Ukrainian law firm ArsLegem) and Iryna Yarotska (a doctor of medicine, obstetrician-gynaecologist, and director of the Academic Medical Centre).
What sets Fertility Ukraine apart from most Ukrainian agencies is the fact that it was established by experienced professionals that prize their reputation and never cut corners. We take personal care in providing services in the sensitive and responsible area as cross-border assisted reproduction.
As an assisted reproduction agency that was founded by experienced and reputable professionals from the area of law and medicine, Fertility Ukraine is perhaps the first (and as of today maybe the only) Ukrainian assisted reproduction agency that is strictly guided by ethical principles and values.
We strive to achieve perfection in everything we do. Starting with legal documents that we prepare for you, procedures related to recruitment and matching of donors and gestational carriers, up to planning and facilitating your journey to parenthood. We also apply very strict quality standards while choosing fertility clinics, maternity hospitals, psychologists or any other specialists involved in your program, ensuring that you receive the best treatment available.
In addition to strict compliance with local laws, Fertility Ukraine applies best practices and ethical standards on a daily basis that were established by such well-known reproductive medicine authorities as, ESHRE and ASRM. We also care about your privacy by using GDPR and HIPAA compliant end-to-end encrypted data storage and file sharing solutions. This approach allows us to minimize risks (both legal and medical) and provides parents added comfort that the entire process is conducted in a professional, ethical, and responsible manner.
Our agency only enters into ethically permissible paid surrogacy arrangements that are based fully on informed consent of all participants. All parties undergo appropriate psychological, medical, and legal counselling. Independent legal counselling also is provided to gestational carriers and the egg donor. We ensure that all parties have an absolutely clear understanding of the requisite benefits and risks. We also make sure that when it comes to compensating gamete donors or gestational carriers, it avoids undue inducement or risk of exploitation.
We are fully sincere and honest in what we do, how we do it, and how we charge for our services and handle any third-party expenses. Most Ukrainian agencies charge a “package” fee that covers “everything” – this creates an inherent conflict of interest because the less they spend on your behalf, the more they earn. We clearly distinguish our fees from any third-party expenses, which are handled separately and are charged at cost. We provide our clients with regular reports, confirmation of receipts, etc. We are on the future family’s side throughout the parenthood journey since we represent your interests and act on your behalf, rather than “sell” you a “package.”
Ukraine is the go-to European destination for such fertility treatments as, donor conception and gestational surrogacy. The reasons are: favourable laws, highly-qualified medical personnel, reputable and well-equipped private clinics, affordable prices, and convenience of travel.
Ukraine is one of the very few European countries where the use of most forms of assisted reproductive technology (ART), including a surrogacy is legal and is highly regulated. Patients have access to egg and sperm donation, preimplantation genetic diagnosis, egg freezing and cryopreservation of embryos, etc. Additionally, married heterosexual couples may conceive through commercial or altruistic gestational surrogacy arrangements. The parental rights of prospective parents are recognized at the moment of conception and both intended parents are listed on the child’s birth certificate with no need for any additional court orders or other formal actions in Ukraine.
The first successful in vitro insemination (IVF) in Ukraine took place in 1984. The first baby born with IVF in Ukraine was in 1991. Currently, there are over 50 private clinics in Ukraine that use ART. Ukrainian statistical rates of clinical pregnancies (36.5%) and successful births (29.5%) are comparable and even higher than the average European country when using combined statistics for all age groups. Successful birth rates using donated eggs and/or surrogates may easily reach figures close to 80%.
Kyiv, the capital of Ukraine, has two international airports with direct flights to most major cities. You may also conveniently travel to many smaller airports throughout Europe with low-cost airlines. No entry visa to Ukraine is required for citizens of over 60 countries (EU states, the U.S., Canada, and Japan). Passport holders of over 50 other countries (e.g. Australia, Mexico, and Saudi Arabia) may apply for electronic visas. Accommodation and transportation could easily be booked on Booking.com, Airbnb.com, Uber, etc.
Ukraine competitively offers affordable prices for high-quality ART treatment. Intended parents are likely to spend less than 50% on treatments with donated eggs or gestational surrogacy, as compared to the same scope and level of services in the U.S. or Canada. What is more important, you get the same level of flexibility and legal comfort, when it comes to choosing oocyte donors or arrangements with a gestational carrier. The same is true for surgical procedures (e.g. laparoscopic surgery for endometriosis, fibroids, etc.) and more simple treatment, like social oocyte cryopreservation.
A procedure in which a small amount of amniotic fluid is removed through a needle from the fetal sac at about 16 weeks into a pregnancy. The fluid is studied for chromosomal or other abnormalities which may affect fetal development.
Antimüllerian hormone (AMH)
A hormone which is often measured in a woman to help determine her egg supply, or “ovarian reserve.” It is secreted by small, growing follicles.
Antral follicle count
The number of follicles noted by ultrasound at the beginning of the menstrual cycle, usually day 2 or 3.
American Society for Reproductive Medicine.
Assisted hatching (AH)
A procedure in which the zona pellucida (outer covering) of the embryo is partially opened, usually by application of an acid or laser, to facilitate embryo implantation and pregnancy.
Assisted reproductive technology (ART)
All treatments which include the handling of eggs and/or embryos. Some examples of ART are in vitro fertilization (IVF), gamete intrafallopian transfer (GIFT), pronuclear stage tubal transfer (PROST), tubal embryo transfer (TET), and zygote intrafallopian transfer (ZIFT).
When a woman’s pregnancy test is initially positive but becomes negative before a gestational sac is visible on ultrasound.
An embryo that has formed a fluid-filled cavity and the cells have begun to form the early placenta and embryo, usually 5 days after ovulation or egg retrieval.
The passageway leading from the vagina into the uterus.
The substance in the cervix through which sperm must swim to enter the uterus.
The narrow, lower end of the uterus.
A pregnancy confirmed by an increasing level of hCG and the presence of a gestational sac detected by ultrasound.
Clomiphene citrate challenge test (CCCT)
A test of ovarian reserve in which serum FSH is checked on days 3 and 10 of the menstrual cycle and clomiphene citrate is taken on days 5 through 9.
An oral antiestrogen medication used to induce ovulation
Freezing at a very low temperature, such as in liquid nitrogen (-196°C) to keep embryos, eggs, or sperm viable.
A pregnancy in the fallopian tube or elsewhere outside the lining of the uterus.
The female sex cell (ovum) produced by the ovary, which, when fertilized by a male’s sperm, produces an embryo.
The procedure in which eggs are obtained by inserting a needle into the ovarian follicle and removing the fluid and the egg by suction. Also called oocyte aspiration.
Procedure to cause ejaculation of sperm, performed by electrical stimulation of tissue in the region of the prostate.
A fertilized egg that has begun cell division.
Growth of the embryo in a laboratory (culture) dish.
Placement of an embryo into the uterus or, in the case of ZIFT and TET, into the fallopian tube.
A disease in which tissue resembling endometrium (the lining of the uterus) grows outside the uterus. It is often associated with infertility.
The duct between testes and vas deferens where sperm are stored and mature.
European Society of Human Reproduction and Embryology.
The predominant estrogen (hormone) produced by the follicular cells of the ovary.
The female hormone largely responsible for thickening the uterine lining during the first half of the menstrual cycle in preparation for ovulation and possible pregnancy. Estradiol is the main estrogen.
A pair of tubes attached to the uterus, one on each side, where sperm and egg meet in normal conception.
The fusion of sperm and egg.
Benign (non-cancerous) tumors of the uterine muscle wall that can cause abnormal uterine bleeding and pain.
A fluid-filled structure in the ovary containing an egg and the surrounding cells that produce hormones. As the follicle matures, the fluid can be visualized by ultrasound.
Follicle-stimulating hormone (FSH)
The pituitary hormone responsible for stimulating the growth of the follicle that surrounds the egg. In addition, it is the hormone in injectable ovulation medications that promotes growth of the follicles.
Gamete intrafallopian transfer (GIFT)
The direct transfer of sperm and eggs into the fallopian tube. Fertilization takes place inside the tube.
A woman who carries a pregnancy for another couple. The pregnancy is derived from the egg and sperm of the couple. Although she carries the pregnancy to term, she does not have a genetic relationship to the resulting child.
Gonadotropin-releasing hormone (GnRH)
Hormone secreted by the hypothalamus, a control center in the brain, which prompts the pituitary gland to release FSH and LH into the bloodstream.
A GnRH analog that initially stimulates the pituitary gland to release LH and FSH, followed by a delayed suppressive effect. GnRH agonists are also used to help stimulate follicle growth when started at the beginning of an IVF cycle.
Synthetic hormones similar to the naturally occurring gonadotropin-releasing hormone used to prevent premature ovulation. There are two types of GnRH analogs: GnRH agonists and GnRH antagonists.
Synthetic hormones similar to the naturally occurring gonadotropin-releasing hormone used to prevent premature ovulation. These medications have an immediate suppressive effect on the pituitary gland.
Human chorionic gonadotropin (hCG)
A hormone produced by the placenta; its detection is the basis for most pregnancy tests. Also refers to the medication used to induce ovulation and during the final stages of egg maturation.
Human menopausal gonadotropin (hMG)
An ovulation drug that contains follicle-stimulating hormone (FSH) and luteinizing hormone (LH) derived from the urine of postmenopausal women. hMG is used to stimulate the growth of multiple follicles.
A blocked, dilated, fluid-filled fallopian tube.
International Federation of Fertility Societies.
Placement of sperm into the uterus or cervix for producing a pregnancy, or adding sperm to eggs in IVF procedures.
Intracytoplasmic sperm injection (ICSI)
A micromanipulation procedure in which a single sperm is injected directly into an egg to attempt fertilization, used with male infertility or couples with prior IVF fertilization failure.
In vitro fertilization (IVF)
A process in which an egg and sperm are combined in a laboratory dish to facilitate fertilization. If fertilized, the resulting embryo is transferred to the uterus.
IVF culture medium
A special fluid into which sperm, eggs, and embryos are placed when outside the human body.
Eine Schwangerschaft, die durch einen erhöhten hCG-Wert und durch das Vorhandensein eines per Ultraschall nachgewiesenen Gestationssacks nachgewiesen wird.
Einfrieren bei einer sehr niedrigen Temperatur, z. B. in flüssigem Stickstoff (-196 °C), um Embryonen, Eizellen oder Spermien lebensfähig zu halten.
A surgical procedure that allows viewing of the internal pelvic organs. During the procedure, a long, narrow, fiber optic instrument, called a laparoscope, is usually inserted through an incision in or below the woman’s navel. One or more additional incisions may be made for inserting additional instruments.
Luteinizing hormone (LH)
The pituitary hormone that normally causes ovulation and maturation of the egg.
Male-factor infertility. Infertility caused by a problem in the male; for example the inability to ejaculate or insufficient number of sperm.
Microepididymal sperm aspiration (MESA)
Outpatient microsurgical procedure used to collect sperm in men with blockage of the male reproductive ducts such as prior vasectomy or absence of the vas deferens. Used in IVF-ICSI procedures.
The IVF laboratory process whereby the egg or embryo is held with special instruments and surgically altered by procedures such as intracytoplasmic sperm injection (ICSI), assisted hatching, or embryo biopsy.
Multifetal pregnancy reduction
Also known as selective reduction. A procedure to reduce the number of fetuses in the uterus. This procedure is sometimes performed on women who are pregnant with multiple fetuses who are at an increased risk of late miscarriage or premature labor. These risks increase with the number of fetuses.
Ovarian hyperstimulation syndrome (OHSS)
A condition that may result from ovulation induction characterized by enlargement of the ovaries, fluid retention, and weight gain.
A woman’s fertility potential in the absence of specific pathophysiologic changes in her reproductive system. Diminished ovarian reserve is associated with depletion in the number of eggs and worsening of oocyte quality.
See Ovulation induction.
The two female sex glands in the pelvis, located one on each side of the uterus. The ovaries produce eggs and hormones including estrogen, progesterone, and androgens.
Release of an egg from the ovary.
The administration of hormone medications (ovulation drugs) that stimulate the ovaries to produce multiple eggs. Sometimes called enhanced follicular recruitment or controlled ovarian hyperstimulation.
Penile vibratory stimulation (PVS)
A procedure to cause ejaculation of sperm, performed by vibratory stimulation of the penis.
Percutaneous epididymal sperm aspiration (PESA)
A sperm aspiration procedure in which a needle is inserted into the epididymis (gland that carries sperm from testicle to vas deferens) in order to retrieve sperm for use in an IVF procedure.
A small gland just beneath the hypothalamus in the brain that secretes follicle-stimulating hormone (FSH) and luteinizing hormone (LH).
A general term that describes any mass of tissue that bulges or projects out or upward from the normal surface level.
Preimplantation genetic diagnosis (PGD)
A test performed by an embryologist in which one or two cells are removed from an embryo. The removed cells are then screened for genetic abnormalities. PGD may be performed in conjunction with IVF.
A female hormone secreted during the second half of the menstrual cycle. It prepares the lining of the uterus for implantation of a fertilized egg.
The nuclei of the male and female gametes (sperm and egg) seen in the one-cell embryo (zygote).
A band of fibrous tissue present from birth that forms a wall within the uterine cavity. A septum may increase the risk of miscarriage and other pregnancy complications.
The fluid ejaculated by the male.
The male reproductive cells that fertilize a woman’s egg. The sperm head carries genetic material (chromosomes), the midpiece produces energy for movement, and the long, thin tail wiggles to propel the sperm.
A birth defect of the spinal column. Spina bifida is the failure of the spine to close properly during development.
Testicular sperm extraction (TESE)
Operative removal of testicular tissue in an attempt to collect living sperm for use in an IVF-ICSI procedure.
A woman who carries a pregnancy intended for an infertile couple. The surrogate’s egg is fertilized with sperm from the male partner of the infertile couple.
Transvaginal ultrasound aspiration
An ultrasound-guided technique for egg retrieval whereby a long, thin needle is passed through the vagina into the ovarian follicle and suction is applied to accomplish retrieval.
A technology that uses high-frequency sound waves to form an image of internal organs on a monitor screen; used by fertility specialists to monitor the growth of ovarian follicles and to retrieve the eggs from the follicles and evaluate a pregnancy.
The hollow, muscular female reproductive organ in the pelvis in which an embryo implants and grows during pregnancy. The lining of the uterus, called the endometrium, produces the monthly menstrual blood flow when there is no pregnancy.
The canal in the female that leads to the cervix, which leads to the uterus.
The two muscular tubes that carry sperm from the epididymis to the urethra.
An ultra-rapid method of freezing eggs and embryos that may offer certain advantages compared with traditional types of cryopreservation.
The egg’s outer layer that a sperm must penetrate in order to fertilize the egg.
A fertilized egg before cell division (cleavage) begins.
Zygote intrafallopian tube transfer (ZIFT)
An egg is fertilized in the laboratory and the zygote is transferred to the fallopian tube before cell division takes place. Eggs are retrieved and fertilized on one day and the embryo is transferred the following day.
The information which is published on this website does not constitute and is not to be used as professional medical or legal advice. Never disregard professional medical or legal advice or delay seeking it because of something you have read on this site.
Use of Materials
We and/or our contributors own all content and materials on the Site, including, without limitation, all trademarks, service marks, trade names and copyrights. Fertility Ukraine grants you free-of-charge access to the content published on the Site. You agree not to sell or modify such content or materials or reproduce, display, publicly perform, distribute, or otherwise use such content or materials in any way for any public or commercial purpose, in connection with products or services that are not those of Fertility Ukraine, in any manner that is likely to cause confusion among consumers, that disparages or discredits us, that dilutes the strength of our property or that otherwise infringes our intellectual property rights.
Application for a Fee Quote and Security
If you applied for a fee quote by using an on-line application form on the Site by providing some personal information, you agree to maintain and update true, accurate and current information about yourself. If you have reasons to believe that your email account is no longer secure, it is your responsibility to let us know immediately. We explicitly disclaim liability for any and all losses and damages arising from your failure to comply with this section.
You agree not to violate or attempt to violate the security of the Site. Violations of system or network security may result in civil or criminal liability. We may investigate occurrences that may involve violations of the law or of the security of the Site. We may involve and cooperate with, law enforcement authorities in prosecuting users who are involved in such violations.
We reserve the right to disclose any information about you or your use of the Site in connection with any investigations by us or law enforcement authorities as may be appropriate or necessary to satisfy any applicable law, regulation, legal process or governmental request.
We may change the Site or delete content or features in any way, at any time and for any reason or no reason.
Compliance with Law
We reserve the right to comply with any subpoena, or order, or otherwise cooperate with law enforcement officials regarding the identification of any user alleged to be using the Site in violation of the law. If we deem appropriate in our sole discretion, we reserve the right to preserve a record of any such information or data and turn all or a portion thereof over to law enforcement officials.
THE INFORMATION, CONTENT AND MATERIALS ON THE SITE ARE PROVIDED “AS IS” AND WITHOUT WARRANTIES OF ANY KIND, EITHER EXPRESSED OR IMPLIED. TO THE FULLEST EXTENT PERMISSIBLE PURSUANT TO APPLICABLE LAW, WE DISCLAIM ALL WARRANTIES, EXPRESS OR IMPLIED, INCLUDED BUT NOT LIMITED TO, IMPLIED WARRANTIES OF MERCHANTABILITIES, FITNESS FOR A PARTICULAR PURPOSE AND NON-INFRINGEMENT. WE DO NOT WARRANT THAT THE SITE WILL BE UNINTERRUPTED OR ERROR-FREE, THAT DEFECTS WILL BE CORRECTED, OR THAT THE SITE OR THE SERVERS THAT MAKE SUCH INFORMATION, CONTENT AND MATERIALS AVAILABLE ARE FREE OF VIRUSES OR OTHER HARMFUL COMPONENTS. WE DO NOT WARRANT OR MAKE ANY REPRESENTATIONS REGARDING THE USE OF THE RESULTS OF THE USE OF ANY INFORMATION, CONTENT, MATERIALS OR SERVICES CONTAINED ON OR OFFERED, MADE AVAILABLE THROUGH, OR OTHERWISE RELATED IN ANY WAY TO THE SITE.
Limitation of Liability
UNDER NO CIRCUMSTANCES, INCLUDING BUT NOT LIMITED TO, NEGLIGENCE, SHALL WE BE LIABLE TO YOU OR ANY OTHER PERSON OR ENTITY FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL OR CONSEQUENTIAL DAMAGES INCLUDING, WITHOUT LIMITATION, LOST PROFITS, PERSONAL INJURY (INCLUDING DEATH) AND PROPERTY DAMAGE OF ANY NATURE WHATSOEVER, THAT RESULT FROM (A) THE USE OF OR INABILITY TO USE THE SITE OR CONTENT, MATERIALS OR FUNCTIONS THEREON, OR (B) THE CONDUCT OR ACTIONS, WHETHER ONLINE OR OFFLINE, OF ANY USER OF THE SITE OR ANY OTHER PERSON OR ENTITY, EVEN IF WE HAVE BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
MOREOVER, UNDER NO CIRCUMSTANCES SHALL WE, OUR LICENSORS OR LICENSEES OR ANY OF THE FOREGOING ENTITIES’ RESPECTIVE RESELLERS, DISTRIBUTORS, SERVICE PROVIDERS AND SUPPLIERS BE HELD LIABLE FOR ANY DELAY OR FAILURE IN PERFORMANCE RESULTING DIRECTLY OR INDIRECTLY FROM AN ACT OF FORCE MAJEURE OR CAUSES BEYOND OUR OR THEIR REASONABLE CONTROL.
YOU FURTHER ACKNOWLEDGE AND AGREE THAT NEITHER WE, NOR OUR LICENSORS OR LICENSEES NOR ANY OF THE FOREGOING ENTITIES’ RESPECTIVE RESELLERS, DISTRIBUTORS, SERVICE PROVIDERS AND SUPPLIERS ARE RESPONSIBLE OR LIABLE FOR (A) ANY INCOMPATIBILITY BETWEEN THE SITE AND ANY WEBSITE, SERVICE, SOFTWARE OR HARDWARE OR (B) ANY DELAYS OR FAILURES YOU MAY EXPERIENCE WITH ANY TRANSMISSIONS OR TRANSACTIONS RELATING TO THE SITE IN AN ACCURATE OR TIMELY MANNER.
Changes to the Term of Use
Information We Collect
When you visit our Site, we collect personal information that you provide to us as well as information we obtain from your use of our Site.
“Personal Information” is information associated with you or that can be used to identify or contact you. This includes contact data such as name, address, and email address.
“Usage Data” is information about your online activity that, by itself, does not identify you, such as:
How We Collect Personal Information
You may browse our Site without submitting Personal Information to us. Personal Information is only collected when you submit information through our on-line application form in order to receive a custom tailored fee quote for our services and related costs. Please note that even in that case we aim to protect your privacy and will not ask for your full name or any other official details (we only ask for your email address and first name to provide a response).
Cookies and Similar Tracking Technologies
What types of cookies do we use and how long do they last?
There are three types of cookies that we use, Necessary Cookies, Analytics Cookies and Advertising Cookies. These cookies perform different functions as explained above the relevant cookies sections below.
We use both first party and third-party cookies. First party cookies are set by the Website you are visiting. Third party cookies are set by a domain which is different to the Website you are visiting, an example of this is where cookies are placed on your device by AddThis.com when you share content from our Website on social media websites.
Cookies can be either session cookies or persistent cookies. Session cookies are cookies which are deleted when you close your internet browser. Persistent cookies stay in place after you have closed your browser, for example, a cookie which tracks whether you are a new or return visitor to the Website. Details on how long these cookies last for are set out in the relevant section below.
Purpose and/or activity: Necessary cookies are essential in order to provide you with the services you request on our Website and in order that we can comply with legal obligations such as our security obligations under data protection law. We do not need to ask for your consent in order to use these cookies as without them we would not be able to provide the services requested by you. These are always active on the Website.
Legal basis for processing: Necessary for our legitimate interests: It is in our interests to be able to provide our Website users with services they request and to enable the operation of our Website.
List of cookies what we use:
How to block all cookies and the consequences of this
If you want to block all cookies, you may be able to do this through the settings in your browser for each browser you use and each device you use to access the internet. Please be aware that some areas of our Website may not work if your browser does not accept cookies. The “Help” function within your web browser should tell you how to make these changes. Alternatively www.allaboutcookies.org provides further information on how to do this and on how to delete cookies.
How We Use Personal Information and Usage Data
We use the Personal Information and Usage Data collected when you use the Site in the following ways:
No Sharing of Your Personal Information
Third Party Sites and Services
We have third party agents that perform functions on our behalf, including but not limited to hosting, content management and social media integration. These entities may have access to Personal Information if needed to perform their functions. If such access is required, the third parties will be obligated to maintain the confidentiality and security of that Personal Information. They are restricted from using, distributing, or altering this data in any way other than to provide the requested services to the Site.
Our Site interacts with social media platforms such as Facebook, Twitter, and others. You should review their privacy policies if you choose to post information from our Site to these platforms.
Fertility Ukraine is not responsible for the privacy practices of these social media sites or other sites linked to our Site.
Access to Your Personal Information and Your Rights
It is important to us that you are able to access and review the Personal Information we have about you. You may, at any time, request to access, verify, correct, delete, and/or transfer your Personal Information. You may also object to the use of your Personal Information or request that its use be limited. To do so, simply send us an email at email@example.com or contact us by mail at the address below.
How We Store and Protect Your Information
We retain information as long as it is necessary to perform our services in accordance with legal requirements and accounting rules. After it is no longer necessary to retain information, we dispose of it in a secure manner.
For a short time your Personal Information may be stored on our in-house servers/devices and then is transferred for storage on a cloud-based servers hosted by our vendors. To better protect your Personal Information we use GDPR and HIPAA compliant end-to end encrypted data storage and file sharing solutions. We employ industry-standard security measures to protect your information, including the use of physical, technical, and administrative controls. We update and test our security technology on an ongoing basis. While we use our best efforts to safeguard your Personal Information once we receive it, any transmission of data over the internet or any other public network carries certain risk.
Our Site is not intended for children under the age of eighteen and we do not knowingly collect Personal Information from children under eighteen years of age. If you are under eighteen years of age, do not provide Personal Information to us without providing us with personal consent from your parents. If we become aware that a child under the age of eighteen has provided us with Personal Information and we do not have parental consent, we will immediately delete that child’s information from our records. If you believe that we have been provided with the Personal Information of a child under the age of eighteen without parental consent, please notify us immediately at firstname.lastname@example.org.
or send us a regular mail:
Fertility Ukraine LLC
Studentska Street 5-7 B
04050, Kyiv, Ukraine